Today: 21 November 2025
Subscribe
Browse Category

Investment Analysis News 14 October 2025 - 16 October 2025

Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Stock Trends and Recent Moves Western Alliance’s stock has been volatile recently. After rallying through summer, it tumbled in early October. On Oct 8, WAL fell about 4% amid headlines that a Jefferies-managed fund (Point Bonita) held ~$715 million in First Brands receivables ts2.tech mlq.ai. By Oct 15, WAL closed near $78.84, down ~4% for the day investing.com. Trading volume surged as investors digested the news. A day later (Oct 16), Reuters reported WAL shares were still down ~5.4% reuters.com, despite the bank’s reassurances. Management disclosed it had filed a fraud lawsuit related to one credit and said its “criticized
16 October 2025
 ·  ·  ·  ·  · 
Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Stock Performance: AI Hype Sends Micron Soaring Micron’s share price momentum in 2025 has been extraordinary. As of October, the stock has more than doubled from January levels, vastly outperforming the S&P 500 and even many tech peers ts2.tech. The rally accelerated in late September and early October when Micron hit fresh record highs, peaking intraday above $196 and closing near $192 ts2.tech. This surge reflects both company-specific optimism and broader “AI mania” lifting the semiconductor sector ts2.tech. Investors have piled into AI-related stocks, and Micron – as a key supplier of memory for AI systems – has been a
16 October 2025
 ·  ·  ·  ·  · 
Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Sea Limited Stock’s Wild Ride: SE Surges 300% Then Plunges – What’s Next for Shopee’s Tech Giant?

Stock Surge and Recent Price Movement Sea Limited’s stock has been on a rollercoaster in 2025. After a brutal 2022–2023 downturn, SE staged a stunning comeback – by August 2025 the share price had more than quadrupled from its early-2024 lows, even briefly overtaking DBS Bank as Southeast Asia’s most valuable public company fintechnews.sg fintechnews.sg. Optimism about Shopee’s profitability and a regional tech rebound propelled Sea’s stock to a 52-week high of ~$199 in early October. However, this week the momentum snapped: on October 15, SE plunged ~10% intraday, falling from about $184 in the morning to close at $163.42
16 October 2025
 ·  ·  ·  ·  · 
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

In mid-October Vivakor’s stock surged amid fresh corporate deals. On Oct. 15 the company revealed it had signed a non-binding term sheet for a $40M commodity intermediation facility globenewswire.com. This arrangement (with a wholesale credit provider) is intended to underwrite letters of credit, bonds or cash deposits to support Vivakor Supply & Trading, LLC’s physical crude oil purchases globenewswire.com. CEO James Ballengee said the deal “highlights our growth initiative for Vivakor’s trading segment,” enabling them to integrate more oil volumes across their trucks and facilities and “driv[e] immediate accretive revenue while diversifying and expanding our crude oil marketing operations” globenewswire.com.
15 October 2025
 ·  ·  ·  ·  · 
Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Stock Snapshot: Recent Price Action After a strong 2025 rally, Sea’s stock has been volatile this week. The shares opened Oct. 15 near $184 (after closing $180.69 on Oct. 14) but slumped to a day’s low of about $162, settling at $163.42 reuters.com. This ~10% one-day drop wiped out weeks of gains, in line with a broader tech selloff. Trading volume on Oct. 15 (~9.16 million shares) far exceeded recent averages reuters.com. Over the past 52 weeks, SE stock traded between $92.50 and $199.30 reuters.com, so even after this pullback the shares remain well above early-year lows. Market watchers point
15 October 2025
 ·  ·  ·  ·  · 
Veritone (NASDAQ: VERI) Stock Soars 50% on Hyperscaler AI Deals – Key Q3 Highlights & Outlook

Veritone (NASDAQ: VERI) Stock Soars 50% on Hyperscaler AI Deals – Key Q3 Highlights & Outlook

Stock Rockets on Contract Wins and Q3 Update Veritone’s shares skyrocketed after the company revealed blockbuster news: it secured new partnerships to deploy its Veritone Data Refinery (VDR) across multiple hyperscalers (industry-speak for the largest cloud platforms) investing.com investing.com. The announcement, made after Tuesday’s market close, immediately lit a fire under the stock – after-hours trades sent VERI up about 53% to $8.36 benzinga.com, an overnight leap reflecting Wall Street’s excitement. By pre-market Wednesday, Veritone was hovering near $8 per share (≈+46% vs. prior close) as investors digested the deal’s significance stockanalysis.com. What sparked the euphoria? In short, Veritone is
15 October 2025
 ·  ·  ·  ·  · 
ASML Stock Soars on AI Mega-Deal as Q3 Earnings Loom – Key Facts and Outlook

ASML Stock Soars on AI Mega-Deal as Q3 Earnings Loom – Key Facts and Outlook

Stock Price and Recent Performance (October 2025) ASML’s stock (Euronext Amsterdam: ASML, also traded as NASDAQ: ASML) has been on a tear going into October 2025. Shares are hovering near their all-time highs after a strong rally in early fall. On October 13, the stock leapt about 5% intraday, closing around $983 (≈€844) after opening near $936 ts2.tech. That surge brought ASML within sight of its 52-week peak (~$1,059) ts2.tech. As of October 15, the price is holding in the high-$900s, reflecting optimism ahead of the company’s earnings release. This recent run-up far outpaced the broader market. Since September 2,
15 October 2025
 ·  ·  ·  · 
Fluence Energy Stock Skyrockets on Battery Boom – Is the FLNC Rally Here to Stay?

Fluence Energy Stock Skyrockets on Battery Boom – Is the FLNC Rally Here to Stay?

October 2025: FLNC Stock Surge Fueled by Policy Tailwinds Fluence Energy’s stock is on a tear in mid-October 2025 after a one-two punch of positive news. On October 14, FLNC spiked to ~$18.50 (up 16% in one day) stockanalysis.com as investors cheered a major JPMorgan investment initiative targeting the clean energy sector. JPMorgan unveiled a decade-long, $1.5 trillion spending program, including $10 billion specifically for battery storage and grid resiliency projects – a direct boon to companies like Fluence stockstory.org. In tandem, CEO Julian Nebreda stoked optimism by revealing surging U.S. demand: power-hungry data centers (driven by the AI boom) are expected to
15 October 2025
 ·  ·  ·  ·  · 
AI Data Center Goldmine or Bubble? Credo (CRDO) Stock’s Wild Ride Amid New Deals and Big Hype

AI Data Center Goldmine or Bubble? Credo (CRDO) Stock’s Wild Ride Amid New Deals and Big Hype

CRDO Stock on a Roller Coaster Ride Credo’s stock has been on a tear – and a turbulent one. Shares have gained over 1,300% since the company’s January 2022 IPO nasdaq.com, vastly outperforming the broader market on excitement around its AI data-center niche. But that stellar run now comes with gut-churning swings. Just in the past few trading days, CRDO went from a steep drop to a euphoric jump and back again. After tumbling ~8% last Friday to $138.83 amid a tech sell-off stockinvest.us, Credo rebounded 7.97% on Monday (Oct. 13) to close near $150 stockinvest.us. The rally was apparently
14 October 2025
 ·  ·  ·  ·  · 
Quantum-Powered Pop! SEALSQ Corp (LAES) Stock Rockets on Latest Breakthroughs and Deals

Quantum Stock Frenzy: SEALSQ (LAES) Soars on Post-Quantum Deals – Analysts Sound Alarm

LAES Stock Skyrockets on Quantum Deal Frenzy SEALSQ’s stock has been on a tear in October, buoyed by a string of strategic announcements that tapped into investor excitement over post-quantum cybersecurity. The shares surged from the $4–5 range in late September to around $6–7 by mid-October, including a 39.7% spike on Oct. 9 alone ts2.tech. On Oct. 14, LAES jumped another ~10% intraday to about $6.70 benzinga.com, briefly testing the $7 level. This powerful momentum has driven LAES to its highest territory in months, far above its summer lows (the stock traded under $1 as recently as 2024) benzinga.com. Traders
14 October 2025
 ·  ·  ·  ·  · 
BCE’s Bold Plan: Bell Slashes Costs & Invades Telus Territory – What It Means for Investors

BCE’s Bold Plan: Bell Slashes Costs & Invades Telus Territory – What It Means for Investors

Bell Invades Telus Territory – A New Era of Competition Bell’s decision to resell fibre internet in Western Canada using Telus’s network is a landmark strategic U-turn. For years, Bell fought against mandated wholesale access to broadband networks, warning it would deter investment iphoneincanada.ca. Telus, conversely, lobbied for these rules and quickly took advantage by expanding into Eastern Canada over Bell’s lines iphoneincanada.ca. Now, faced with the reality of the regulator’s decision, Bell is adopting an “if you can’t beat ’em, join ’em” approach iphoneincanada.ca. Under the CRTC’s wholesale fibre policy, large telcos must sell network access to competitors at
14 October 2025
 ·  ·  ·  ·  · 
Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata’s XTRAC® excimer laser (pictured above) is a targeted UVB therapy device used to treat localized skin conditions like psoriasis, vitiligo, and eczema biospace.com globenewswire.com. By customizing UV dose to each patient’s lesion, XTRAC spares healthy skin and enables precision treatment (often via a fee-per-treatment partnership model rather than equipment sales) globenewswire.com biospace.com. Company Background STRATA Skin Sciences, Inc. is a medical tech company specializing in dermatologic treatments. Its core product is the XTRAC® 308nm Excimer Laser – a handheld UVB laser used in doctors’ offices to zap diseased skin with high-intensity, targeted light. XTRAC is FDA-cleared for conditions like
14 October 2025
 ·  ·  ·  ·  · 
1 … 24 25 26 27 28 … 31
Go toTop